These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 25999403)
1. Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease. Saigusa T; Dang Y; Bunni MA; Amria MY; Steele SL; Fitzgibbon WR; Bell PD Physiol Rep; 2015 May; 3(5):. PubMed ID: 25999403 [TBL] [Abstract][Full Text] [Related]
2. Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade. Fitzgibbon WR; Dang Y; Bunni MA; Baicu CF; Zile MR; Mullick AE; Saigusa T Am J Physiol Renal Physiol; 2018 Feb; 314(2):F210-F218. PubMed ID: 29021226 [TBL] [Abstract][Full Text] [Related]
3. Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model. Saigusa T; Dang Y; Mullick AE; Yeh ST; Zile MR; Baicu CF; Bell PD FASEB J; 2016 Jan; 30(1):370-9. PubMed ID: 26391272 [TBL] [Abstract][Full Text] [Related]
4. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Loghman-Adham M; Soto CE; Inagami T; Cassis L Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005 [TBL] [Abstract][Full Text] [Related]
5. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Kobori H; Nangaku M; Navar LG; Nishiyama A Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513 [TBL] [Abstract][Full Text] [Related]
6. The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors. Ohashi N; Isobe S; Matsuyama T; Ishigaki S; Suzuki T; Tsuji T; Otsuka A; Kato A; Miyake H; Yasuda H Intern Med; 2019 Mar; 58(5):643-648. PubMed ID: 30333423 [TBL] [Abstract][Full Text] [Related]
7. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function. Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779 [TBL] [Abstract][Full Text] [Related]
8. Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease. Loghman-Adham M; Soto CE; Inagami T; Sotelo-Avila C J Histochem Cytochem; 2005 Aug; 53(8):979-88. PubMed ID: 15879580 [TBL] [Abstract][Full Text] [Related]
9. Role of stimulated intrarenal angiotensinogen in hypertension. Satou R; Shao W; Navar LG Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):181-90. PubMed ID: 25987608 [TBL] [Abstract][Full Text] [Related]
10. Renin and the (pro)renin receptor in the renal collecting duct: Role in the pathogenesis of hypertension. Gonzalez AA; Prieto MC Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):14-21. PubMed ID: 25371190 [TBL] [Abstract][Full Text] [Related]
11. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nauli SM; Alenghat FJ; Luo Y; Williams E; Vassilev P; Li X; Elia AE; Lu W; Brown EM; Quinn SJ; Ingber DE; Zhou J Nat Genet; 2003 Feb; 33(2):129-37. PubMed ID: 12514735 [TBL] [Abstract][Full Text] [Related]
12. Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease. Kobori H; Navar LG Int Rev Thromb; 2011; 6(2):108-116. PubMed ID: 22022346 [TBL] [Abstract][Full Text] [Related]
13. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients. Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580 [TBL] [Abstract][Full Text] [Related]
15. The evolving complexity of the collecting duct renin-angiotensin system in hypertension. Prieto MC; Gonzalez AA; Visniauskas B; Navar LG Nat Rev Nephrol; 2021 Jul; 17(7):481-492. PubMed ID: 33824491 [TBL] [Abstract][Full Text] [Related]
16. Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study. Kim H; Park S; Jhee JH; Yun HR; Park JT; Han SH; Lee J; Kim SW; Kim YH; Oh YK; Kang SW; Choi KH; Yoo TH; BMC Nephrol; 2019 Mar; 20(1):104. PubMed ID: 30909873 [TBL] [Abstract][Full Text] [Related]
17. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease. Kocyigit I; Yilmaz MI; Unal A; Ozturk F; Eroglu E; Yazici C; Orscelik O; Sipahioglu MH; Tokgoz B; Oymak O Am J Nephrol; 2013; 38(3):218-25. PubMed ID: 23988725 [TBL] [Abstract][Full Text] [Related]
18. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats. Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146 [TBL] [Abstract][Full Text] [Related]
19. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Ohashi N; Isobe S; Ishigaki S; Yasuda H Hypertens Res; 2017 May; 40(5):413-422. PubMed ID: 27904154 [TBL] [Abstract][Full Text] [Related]
20. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]